Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions

Completed · Not applicable

Conditions studied: Hypertension

In brief

The objective of this study was to prove the bioequivalence of Ramipril 10 mg capsules under fasting conditions.

Key facts

Study ID

NCT00702091

Run by

Roxane Laboratories

People needed

39

Starts

2005-01-01

Expected to finish

2005-01-01

Last updated by the study team

2018-01-23

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening

You may not qualify if…

• Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to Ramipril or any comparable or similar product.

Where it is running

• CEDRA Clinical Research, LLC — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.